First Time Loading...

Chembio Diagnostics Inc
NASDAQ:CEMI

Watchlist Manager
Chembio Diagnostics Inc Logo
Chembio Diagnostics Inc
NASDAQ:CEMI
Watchlist
Price: 0.455 USD 0.22% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

CEMI doesn't have a meaningful market cap.
CEMI's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. [ Read More ]

The intrinsic value of one CEMI stock under the Base Case scenario is 0.067 USD. Compared to the current market price of 0.455 USD, Chembio Diagnostics Inc is Overvalued by 85%.

Key Points:
CEMI Intrinsic Value
Base Case
0.067 USD
Overvaluation 85%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Chembio Diagnostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CEMI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Chembio Diagnostics Inc

Provide an overview of the primary business activities
of Chembio Diagnostics Inc.

What unique competitive advantages
does Chembio Diagnostics Inc hold over its rivals?

What risks and challenges
does Chembio Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Chembio Diagnostics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chembio Diagnostics Inc.

Provide P/S
for Chembio Diagnostics Inc.

Provide P/E
for Chembio Diagnostics Inc.

Provide P/OCF
for Chembio Diagnostics Inc.

Provide P/FCFE
for Chembio Diagnostics Inc.

Provide P/B
for Chembio Diagnostics Inc.

Provide EV/S
for Chembio Diagnostics Inc.

Provide EV/GP
for Chembio Diagnostics Inc.

Provide EV/EBITDA
for Chembio Diagnostics Inc.

Provide EV/EBIT
for Chembio Diagnostics Inc.

Provide EV/OCF
for Chembio Diagnostics Inc.

Provide EV/FCFF
for Chembio Diagnostics Inc.

Provide EV/IC
for Chembio Diagnostics Inc.

Show me price targets
for Chembio Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Chembio Diagnostics Inc?

How accurate were the past Revenue estimates
for Chembio Diagnostics Inc?

What are the Net Income projections
for Chembio Diagnostics Inc?

How accurate were the past Net Income estimates
for Chembio Diagnostics Inc?

What are the EPS projections
for Chembio Diagnostics Inc?

How accurate were the past EPS estimates
for Chembio Diagnostics Inc?

What are the EBIT projections
for Chembio Diagnostics Inc?

How accurate were the past EBIT estimates
for Chembio Diagnostics Inc?

Compare the revenue forecasts
for Chembio Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chembio Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chembio Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chembio Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Chembio Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Chembio Diagnostics Inc with its peers.

Analyze the financial leverage
of Chembio Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Chembio Diagnostics Inc.

Provide ROE
for Chembio Diagnostics Inc.

Provide ROA
for Chembio Diagnostics Inc.

Provide ROIC
for Chembio Diagnostics Inc.

Provide ROCE
for Chembio Diagnostics Inc.

Provide Gross Margin
for Chembio Diagnostics Inc.

Provide Operating Margin
for Chembio Diagnostics Inc.

Provide Net Margin
for Chembio Diagnostics Inc.

Provide FCF Margin
for Chembio Diagnostics Inc.

Show all solvency ratios
for Chembio Diagnostics Inc.

Provide D/E Ratio
for Chembio Diagnostics Inc.

Provide D/A Ratio
for Chembio Diagnostics Inc.

Provide Interest Coverage Ratio
for Chembio Diagnostics Inc.

Provide Altman Z-Score Ratio
for Chembio Diagnostics Inc.

Provide Quick Ratio
for Chembio Diagnostics Inc.

Provide Current Ratio
for Chembio Diagnostics Inc.

Provide Cash Ratio
for Chembio Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Chembio Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Chembio Diagnostics Inc?

What is the current Free Cash Flow
of Chembio Diagnostics Inc?

Financials

Balance Sheet Decomposition
Chembio Diagnostics Inc

Current Assets 48.5m
Cash & Short-Term Investments 18.2m
Receivables 18.7m
Other Current Assets 11.5m
Non-Current Assets 14.2m
PP&E 13.7m
Other Non-Current Assets 434.9k
Current Liabilities 39.3m
Accounts Payable 3.3m
Accrued Liabilities 17.3m
Other Current Liabilities 18.7m
Non-Current Liabilities 5.5m
Long-Term Debt 86.9k
Other Non-Current Liabilities 5.4m
Efficiency

Earnings Waterfall
Chembio Diagnostics Inc

Revenue
49.5m USD
Cost of Revenue
-38.6m USD
Gross Profit
10.9m USD
Operating Expenses
-31.3m USD
Operating Income
-20.4m USD
Other Expenses
-2.9m USD
Net Income
-23.3m USD

Free Cash Flow Analysis
Chembio Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CEMI Profitability Score
Profitability Due Diligence

Chembio Diagnostics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

Chembio Diagnostics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

CEMI Solvency Score
Solvency Due Diligence

Chembio Diagnostics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Chembio Diagnostics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CEMI Price Targets Summary
Chembio Diagnostics Inc

There are no price targets for CEMI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CEMI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CEMI Price
Chembio Diagnostics Inc

1M 1M
-
6M 6M
-
1Y 1Y
+1%
3Y 3Y
-87%
5Y 5Y
-94%
10Y 10Y
-85%
Annual Price Range
0.455
52w Low
0.45
52w High
0.462
Price Metrics
Average Annual Return -33.14%
Standard Deviation of Annual Returns 43.49%
Max Drawdown -99%
Shares Statistics
Market Capitalization 16.7m USD
Shares Outstanding 36 725 900
Percentage of Shares Shorted 0.82%

CEMI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Chembio Diagnostics Inc Logo
Chembio Diagnostics Inc

Country

United States of America

Industry

Health Care

Market Cap

16.7m USD

Dividend Yield

0%

Description

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. The company is headquartered in Hauppauge, New York and currently employs 337 full-time employees. The company went IPO on 2000-10-18. Its product portfolio is based upon its DPP technology, a diagnostic platform that provides results in 15 to 20 minutes using fingertip blood, nasal swabs, and other sample types. The DPP technology platform addresses the rapid diagnostic test market, which includes infectious diseases such as sexually transmitted infections (STIs) and human immunodeficiency virus (HIV), gastroenterology, and women's health. Its products include COVID-19 Antibody Test System, COVID-19 Antigen Test System, COVID-19 and Influenza Respiratory Antigen Panel Test System and HIV-Syphilis Diagnostic Test Systems, among others. The company is also targeting lateral flow test solutions for infectious diseases.

Contact

NEW YORK
Hauppauge
555 Wireless Blvd
+16319241135.0
http://chembio.com/

IPO

2000-10-18

Employees

337

Officers

Pres, CEO & Director
Mr. Richard L. Eberly
Exec. VP and Chief Scientific & Technology Officer
Mr. Javan Esfandiari
Exec. VP, CFO & Sec.
Mr. Lawrence J. Steenvoorden CPA
Exec. VP & COO
Mr. Paul J. Angelico
VP of HR
Ms. Stella Rivera
Sr. VP of Global Commercial Operations
Mr. Charles Caso
Show More
Research Director of Chembio Diagnostic Systems Inc
Dr. Konstantin Lyashchenko
Show Less

See Also

Discover More
What is the Intrinsic Value of one CEMI stock?

The intrinsic value of one CEMI stock under the Base Case scenario is 0.067 USD.

Is CEMI stock undervalued or overvalued?

Compared to the current market price of 0.455 USD, Chembio Diagnostics Inc is Overvalued by 85%.